This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Dermatologic Surgery  • Alert me on articles by topic

". . . A Far, Far Better Thing That I Do"*

Arch Dermatol. 2004;140:743-744.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Nonmelanoma skin cancer (NMSC)¹and melanoma² are epidemic in the United States. One analysis of a large prepaid health insurance program indicated that the incidence of squamous cell carcinoma (SCC) increased by 2.6 times in men and 3.1 times in women over a 20-year period from the 1960s to the 1980s.³ Another large study put the increase in SCC from 1980 to 1994 at 235% in men and 350% in women and the increase in basal cell skin cancer (BCC) at more than 80% in both sexes.⁴

Nonmelanoma skin cancer is diagnosed and treated each year by a variety of specialists but predominantly by dermatologists. All specialists, including dermatologists, plastic surgeons, general surgeons, otolaryngologists, family medicine practitioners, and radiation oncologists, treat these tumors according to their own training and experience. The optimal surgical approach, considering cure rates and cost, is still open for discussion. Bialy and colleagues⁵ have performed an . . . [Full Text of this Article]

Daniel Mark Siegel, MD
Department of Dermatology
State University of New York Downstate Medical Center
450 Clarkson Ave, Box 46
Brooklyn, NY 11203
(e-mail: cyberdoc@alum.rpi.edu)

Brett M. Coldiron, MD
Cincinnati, Ohio

RELATED ARTICLE

Mohs Micrographic Surgery vs Traditional Surgical Excision: A Cost Comparison Analysis
Tracy L. Bialy, James Whalen, Emir Veledar, Denis Lafreniere, Jeffrey Spiro, Timothy Chartier, and Suephy C. Chen
Arch Dermatol. 2004;140(6):736-742.
ABSTRACT | FULL TEXT